-
1 Comment
Jointown Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 13.6% below its 200 day moving average.
From a valuation standpoint, the stock is 96.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Jointown Pharmaceutical Group Co., Ltd's total revenue rose by 16.1% to $29B since the same quarter in the previous year.
Its net income has increased by 220.4% to $882M since the same quarter in the previous year.
Finally, its free cash flow grew by 850.9% to $799M since the same quarter in the previous year.
Based on the above factors, Jointown Pharmaceutical Group Co., Ltd gets an overall score of 4/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100000W45 |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Beta | 0.32 |
|---|---|
| Market Cap | 26B |
| PE Ratio | 9.55 |
| Target Price | 7.38 |
| Dividend Yield | 3.6% |
Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added services; and digital logistics and supply chain solutions. The company was founded in 1999 and is headquartered in Wuhan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600998.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
